WASHINGTON (TND) — Earlier this month, the U.S. Food and Drug Administration added a warning to gonadotropin-releasing hormone (GnRH) agonists, commonly known as “puberty blockers,” indicating there were serious risks for youth who take them.
The U.S. Food and Drug Administration (FDA) identified six cases in females between the ages of 5 and 12, who were taking GnRH agonists, which presented “a plausible association between GnRH agonist use and pseudotumor cerebri.”
Pseudotumor cerebri, also known as idiopathic intracranial hypertension, occurs when the pressure inside your skull spontaneously increases, which can cause brain swelling, severe headaches, nausea, double vision, and even permanent vision loss, according to the Mayo Clinic.
Views: